Indian Journal of Microbiology

, Volume 51, Issue 3, pp 273–278 | Cite as

Virulence Factors and Anti Fungal Sensitivity Pattern of Candida Sp. Isolated from HIV and TB Patients

  • Nachimuthu Ramesh
  • Maruthupandian Priyadharsini
  • Chettipalayam Samiappan Sumathi
  • Velramar Balasubramanian
  • Janarthanam Hemapriya
  • Rajesh kannan
Original Article


The study comprised of 60 Candida spp., 50 isolates from HIV and TB positive individuals (immunocompromised) and 10 isolates from non-HIV and -TB patients (immunocompetent). Among the 60 Candidal isolates, 83.3% were identified as C. albicans, 11.6% as C. glabrata and rest 5% as C. krusei. There is no study in production pattern of extracellular enzymes of Candida spp. isolated from HIV and TB patients in comparison with non-HIV and -TB patients in India. The comparison of phospholipase activities showed that there was a significant difference between the groups at (P = 0.001). The non-HIV and -TB groups of C. glabrata and C. krusei did not show detectable phospholipase activity when compared to the HIV and TB groups. The mean difference in the phospholipase activities of these two groups was significant (P = <0.001). Candida spp. of both the groups do not possess the ability to hydrolyze gelatin. All the strains possessed the ability to show alpha haemolysis. Even though it had shown alpha haemolysis, the significant difference in haemolytic activity was observed only in C. albicans (P = <0.001). None of the isolates from the two groups possessed the ability to hydrolyze gelatin. In the resistance profile of Candida spp., C. albicans of HIV and TB groups had shown resistance to fluconazole, Itraconazole, ketaconazole, nystatin but showed 100% sensitivity towards amphotericin-B. The isolates of C. krusei and C. glabrata showed no resistance to any of the drugs tested. In the case of, non-HIV and -TB patients the resistance pattern was low.


Candida Protease Lipase Fluconazole HIV TB 



The authors greatly acknowledge Dr. Sys Reetha MD, (Italy) and Dr. M. Santhosh Kumar, Holy Hanchanorium Community Care Centre, Trichy, and Dr. Shanmugasundram, District Project Manager, AIDS Control Board, Trichy.


  1. 1.
    Chung YL, Emily CDS, Heng FS, Rozita R, Kee PN, Pei PC (2005) Increased expression and hot spot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients. FEMS Microbiol Lett 249:283–289CrossRefGoogle Scholar
  2. 2.
    Calderone RA (2002) Candida and candidiasis. ASM Press, WashingtonGoogle Scholar
  3. 3.
    Eggimann P, Garbino J, Pittet D (2003) Epidemiology of Candida species infections in critically ill non-immuno suppressed patients. Lancet Infect Dis 3:685–702PubMedCrossRefGoogle Scholar
  4. 4.
    Jain SK, Agarwal RL, Sharma DA, Agarwal MM (1982) Candida in pulmonary tuberculosis. J Postgrad Med 19:24–28Google Scholar
  5. 5.
    Walia K (2002) Current issues in HIV/TB co-infection. Indian J Tub 49:21Google Scholar
  6. 6.
    Naglik J, Albrecht A, Bader O, Hube B (2004) Candida albicans proteinases and host/pathogen interactions. Cell Microbiol 6:915–926PubMedCrossRefGoogle Scholar
  7. 7.
    Belanger M, Begin C, Jacques M (1995) Ipopolysaccharides of Actinobacillus pleuropneumoniae bind pig hemoglobin. Infect Immun 63:656–662PubMedGoogle Scholar
  8. 8.
    Boerlin P, Berlin-Petzold F, Durussel C, Addo M, Pagani JL, Chave JP, Bille J (1995) Cluster of oral atypical Candida albicans isolates in a group of human immunodefiency virus-positive drug users. J Clin Microbial 33:1129–1135Google Scholar
  9. 9.
    Perea S, Patterson TF (2002) Antifungal resistance in pathogenic fungi. Clin Infect Dis 35:1073–1080PubMedCrossRefGoogle Scholar
  10. 10.
    Kreger-Van Rij NJW (ed) (1984) The yeasts a taxonomic study (1982). Elsevier Science Publishers, AmsterdamGoogle Scholar
  11. 11.
    Price MF, Wilkinson ID, Gentry LO (1982) Plate method for the detection of phospholipase activity in Candida albicans. Sabouraudia 20:7–14PubMedCrossRefGoogle Scholar
  12. 12.
    de Doroti OG, Jorge T, Marina BM, Wldemar F, Sinto S, Roberto MY (2002) Proteases (caseinase, elastinase), hemolysins, adhesion and susceptibility to antimicrobials of Stenotrophomonas maltophilia isolates obtained from clinical specimens. J Microbiol 33:157–162Google Scholar
  13. 13.
    Jacob MB, Gerstein MJ (1960) Hand book of microbiology. D. Van Nostrand Co. Inc., Princeton, p 61Google Scholar
  14. 14.
    Aneeja KR (1996) Experiments in microbiology, plant pathology, tissue culture and mushroom cultivation, II edn. New Age International Publishers, DelhiGoogle Scholar
  15. 15.
    Manns JM, Mosser DM, Buckley HR (1994) Production of haemolytic factor by Candida albicans. Infect Immun 62:5154–5156PubMedGoogle Scholar
  16. 16.
    LS NCC (2002) Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi: proposed standards. NCCLS document M38-A. National Committee for Clinical Laboratory Standards, WayneGoogle Scholar
  17. 17.
    Sukru O, Idris S, Mustafa Y, Aynur G, Tevfik Y, Demet K, Ayse NK (2007) Phospholipase and proteinase activities in different Candida species isolated from anatomically distinct sites of healthy adults. Jpn J Infect Dis 60:280–283Google Scholar
  18. 18.
    Silverman DJ, Santucci LA, Meyers N, Sekeyova Z (1992) Penetration of host cells by Rickettsia rickettsii appears to be mediated by a phospholipase of rickettsial origin. Infect Immun 60:2733–2740PubMedGoogle Scholar
  19. 19.
    Kantarcioglu AS, Yucel A (2002) Phospholipase and protease activities in Candida isolates with reference to the sources of strains. Mycoses 45:160–165PubMedCrossRefGoogle Scholar
  20. 20.
    Kusmarinah B, Masashi Y, Ryoji T, Hideoki O (2006) Comparison of proteinase, lipase and alpha glucosidase activities from the clinical isolates of Candida species. Jpn J Infect Dis 59(2):73–76Google Scholar
  21. 21.
    Martin S, Borelli C, Korting HC, Hube B (2005) Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 48:365–37719CrossRefGoogle Scholar
  22. 22.
    Gang L, Lakshman P, Samaranayake LP, Joyce Y, Yau Y (2001) Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol 39:2971–2974CrossRefGoogle Scholar
  23. 23.
    Eveline PM, Marcelo NB, Esper GK, Olga F, Paulo R, Costa O, Arnaldo LC (1998) Azole resistance among oral Candida species isolates from aids patients under ketoconazole exposure. Diagn Microbiol Infect Dis 2:211–216Google Scholar
  24. 24.
    Jana C (2006) Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis. Int J Antimicrob Agents 29(2):117–232Google Scholar
  25. 25.
    Kurtaran B, Inal AS, Kibar F, Yaman A, Tasova Y, Saltoglu N, Aksu HSZ (2005) The epidemiology and antifungal sensitivity results of nosocomial infections caused by Candida species. 15th congress of clinical microbiology and infectious diseases. Copenhagen, Denmark, 2–5 April 2005Google Scholar

Copyright information

© Association of Microbiologists of India 2011

Authors and Affiliations

  • Nachimuthu Ramesh
    • 1
  • Maruthupandian Priyadharsini
    • 1
  • Chettipalayam Samiappan Sumathi
    • 1
  • Velramar Balasubramanian
    • 1
  • Janarthanam Hemapriya
    • 1
  • Rajesh kannan
    • 1
  1. 1.Department of MicrobiologyBharathidasan UniversityTiruchirappalliIndia

Personalised recommendations